245 related articles for article (PubMed ID: 30895944)
1. Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
Rosenberg AR; Tabacchi M; Ngo KH; Wallendorf M; Rosman IS; Cornelius LA; Demehri S
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30895944
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Cunningham TJ; Tabacchi M; Eliane JP; Tuchayi SM; Manivasagam S; Mirzaalian H; Turkoz A; Kopan R; Schaffer A; Saavedra AP; Wallendorf M; Cornelius LA; Demehri S
J Clin Invest; 2017 Jan; 127(1):106-116. PubMed ID: 27869649
[TBL] [Abstract][Full Text] [Related]
3. Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
Mohney L; Singh R; Grada A; Feldman S
J Drugs Dermatol; 2022 Jan; 21(1):60-65. PubMed ID: 35005863
[TBL] [Abstract][Full Text] [Related]
4. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
Yoon J; Phibbs CS; Chow A; Weinstock MA;
J Am Acad Dermatol; 2018 Sep; 79(3):501-507.e2. PubMed ID: 29505863
[TBL] [Abstract][Full Text] [Related]
5. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
[TBL] [Abstract][Full Text] [Related]
6. Facial resurfacing for nonmelanoma skin cancer prophylaxis.
Hantash BM; Stewart DB; Cooper ZA; Rehmus WE; Koch RJ; Swetter SM
Arch Dermatol; 2006 Aug; 142(8):976-82. PubMed ID: 16924046
[TBL] [Abstract][Full Text] [Related]
7. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM
J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
Philipp-Dormston WG; Müller K; Novak B; Strömer K; Termeer C; Hammann U; Glutsch JW; Krähn-Senftleben G; Lübbert H; Koller M; Szeimies RM;
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1138-1146. PubMed ID: 29150868
[TBL] [Abstract][Full Text] [Related]
9. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
[TBL] [Abstract][Full Text] [Related]
10. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
[TBL] [Abstract][Full Text] [Related]
12. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
Keller B; Braathen LR; Marti HP; Hunger RE
Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
[TBL] [Abstract][Full Text] [Related]
13. Field cancerization: Treatment.
Cornejo CM; Jambusaria-Pahlajani A; Willenbrink TJ; Schmults CD; Arron ST; Ruiz ES
J Am Acad Dermatol; 2020 Sep; 83(3):719-730. PubMed ID: 32387663
[TBL] [Abstract][Full Text] [Related]
14. High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma.
Boone MA; Marneffe A; Suppa M; Miyamoto M; Alarcon I; Hofmann-Wellenhof R; Malvehy J; Pellacani G; Del Marmol V
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1606-15. PubMed ID: 25656269
[TBL] [Abstract][Full Text] [Related]
15. Expression of Podoplanin in Non-melanoma Skin Cancers and Actinic Keratosis.
Wojciechowska-Zdrojowy M; Szepietowski JC; Matusiak Ł; Dzięgiel P; Puła B
Anticancer Res; 2016 Apr; 36(4):1591-7. PubMed ID: 27069135
[TBL] [Abstract][Full Text] [Related]
16. A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes.
Wood DLA; Lachner N; Tan JM; Tang S; Angel N; Laino A; Linedale R; Lê Cao KA; Morrison M; Frazer IH; Soyer HP; Hugenholtz P
mBio; 2018 Oct; 9(5):. PubMed ID: 30301852
[TBL] [Abstract][Full Text] [Related]
17. Treatment of squamous cell carcinoma with intralesional 5-Fluorouracil.
Morse LG; Kendrick C; Hooper D; Ward H; Parry E
Dermatol Surg; 2003 Nov; 29(11):1150-3; discussion 1153. PubMed ID: 14641346
[TBL] [Abstract][Full Text] [Related]
18. Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults.
Foote JA; Harris RB; Giuliano AR; Roe DJ; Moon TE; Cartmel B; Alberts DS
Int J Cancer; 2001 Jan; 95(1):7-11. PubMed ID: 11241303
[TBL] [Abstract][Full Text] [Related]
19. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
20. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
Torezan L; Grinblat B; Haedersdal M; Valente N; Festa-Neto C; Szeimies RM
Br J Dermatol; 2018 Oct; 179(4):829-835. PubMed ID: 29476546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]